- Home
- / Shanghai Microport Medbot
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Shanghai Microport Medbot financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$9.2
2024-10-29
Market Capitalization
$8.6 B
2024-10-29
Revenue
¥551.1 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.2M | 21.6M | 104.6M | 257.2M | 551.1M | ||
| Cost of goods sold | 1.2M | 15.0M | 39.0M | 59.0M | 178.1M | ||
| Gross profit | 2.2M | 2.4M | 12.6M | 19.9M | 85.1M | 210.4M | 400.6M |
| Gross profit margin, % | 587.7% | 92.3% | 81.3% | 81.8% | 72.7% | ||
| Operating expense total | 69.4M | 160.5M | 587.4M | 1.0B | 873.1M | 566.1M | 462.6M |
| Depreciation and amortization | 3.1M | 4.5M | 35.4M | 100.7M | 111.8M | 117.8M | 140.3M |
| EBITDA | (67.2M) | (159.8M) | (602.2M) | (1.0B) | (817.8M) | (376.0M) | (63.1M) |
| EBITDA margin, % | -28008.4% | -4795.3% | -781.9% | -146.1% | -11.4% | ||
| EBIT | (70.3M) | (164.3M) | (637.6M) | (1.1B) | (971.5M) | (510.8M) | (213.7M) |
| EBIT margin, % | -29653.7% | -5261.4% | -928.8% | -198.6% | -38.8% | ||
| Interest income | 1.1M | 8.1M | 22.1M | 26.7M | 8.9M | 2.2M | 6.8M |
| Interest expense | 531.0K | 49.2M | 5.4M | 11.4M | 18.6M | 21.6M | 19.8M |
| Pre tax profit | (69.8M) | (209.3M) | (584.5M) | (1.1B) | (1.0B) | (647.1M) | (254.1M) |
| Net Income | (69.8M) | (209.3M) | (584.5M) | (1.1B) | (1.0B) | (647.1M) | (254.1M) |